Maël Heiblig

centre hospitalier lyon sud

H指数:26

被引数:3,207

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Oral Azacitidine Maintenance After CPX-351 in Transplant-Ineligible Patients With Therapy-Related or Myelodysplasia-Related Acute Myeloid Leukemia

在移植不适宜的继发性或骨髓增生异常综合征相关急性髓系白血病患者中，CPX-351治疗后口服阿扎胞苷维持治疗

American Journal of Hematology

IF9.9

2026-10-120

OAAI

Ruxolitinib for life-threatening corticosteroid-refractory hypereosinophilic syndrome: A multicenter case series

鲁索利替尼治疗危及生命且对皮质类固醇无反应的高嗜酸性粒细胞综合征：一项多中心病例系列研究

Clinical Immunology

IF3.8

2026-09-290

PRE

Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI)

开发用于评估VEXAS综合征（VEXAS-DAI）疾病活动度的指数

ARTHRITIS CARE & RESEARCH

IF3.3

2026-09-080

OAAI

Kevin Byram MD; Heřman Mann MD, PhD; Danielle Hammond MD; Onima Chowdhury DPhil; Sinisa Savic MBBS; Yohei Kirino MD, PhD; Carmelo Gurnari MD, PhD; Maël Heiblig MD; Thibault Comont MD; Arsène Mekinian MD, PhD; Mrinal M. Patnaik MBBS; Lachelle D. Weeks MD, PhD; Gary Ho MD; Adam Al-Hakim MRCP; Scott Goldberg MD; Marcela A. Ferrada MD; Sophie Georgin-Lavialle MD, PhD; Peter C. Grayson MD, MSc; Emma M. Groarke MD; Bhavisha Patel MD; Megan Sullivan MD; Sarah A. Buckley MD; Bryan G. Harder PhD; Raman Garcha MD; David B. Beck MD, PhD; Matthew J. Koster MD

Comparison of venetoclax and azacitidine versus a cytarabine-based treatment for patients with acute myeloid leukaemia in first relapse after chemotherapy. A real-world study of the DATAML-IPC-AURAML consortium

比较维奈克拉和阿扎胞苷与基于阿糖胞苷的治疗方案在化疗后首次复发的急性髓系白血病患者的疗效：DATAML-IPC-AURAML联盟的真实世界研究

British Journal of Haematology

IF3.8

2026-09-060

OAAI

Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry

初治AML患者接受阿扎胞苷和维奈克拉治疗时可测量残留疾病对预后的影响：法国VENAURA登记研究的结果

Leukemia

IF13.4

2026-07-170

OAAI

Maël Heiblig; Zofia Gross; Amine Belhabri; Urbain Tauveron-Jalenques; Emmanuelle Tavernier; Gaspar Requena Aspas; Martin Carré; Adrien Contejean; Nadine Boullanger Fow Heng; Clémence Santana; Clément Rocher; Sylvain Lamure; Gian-Matteo Pica; Mauricette Michallet; Jérôme Cornillon; Mathieu Meunier; Natacha Mauz; Samy Chraibi; Ugo Thevenet; Arthur Dony; Grégoire Le Meur; Lucie Coster; Sylvie Tondeur; Emmanuel Beillard; Serge Carillo; Delphine Manzoni; Pascale Flandrin; Thomas Tassin; Sarah Huet; Adriana Plesa

Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy

年轻急性髓系白血病患者接受强化化疗治疗后FLT3-ITD微克隆的预后影响

Blood

IF23.1

2026-05-250

PRE

Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement

NUP98重排的成人急性髓系白血病患者的综合突变谱和临床结局

Leukemia

IF13.4

2026-05-120

PRE

Benoit Ducourneau; Arnaud Pages; Stéphanie Struski; Matthieu Decamp; Emmanuel Raffoux; Céline Berthon; Laurène Fenwarth; Vincent Marmouset; Cécile Pautas; Thomas Cluzeau; Delphine Lebon; Madalina Uzunov; Patricio Pereyra; Maël Heiblig; Jean-Valère Malfuson; Laure Farnault; Pierre-Yves Dumas; Julia Hieulle; Sarah Bertoli; Sylvain Chantepie; Nathalie Auger; Audrey Bidet; Marie-Joelle Mozziconacci; Augustin Boudry; Isabelle Luquet; Laureen Chat; Romain Loyaux; Lina El-Mur; Emmanuelle Clappier; Claude Gardin; Mathilde Hunault; Stéphane De Botton; Arnaud Pigneux; Dominique Penther; Eric Delabesse; Raphael Itzykson; Claude Preudhomme; Hervé Dombret; Christian Recher; Nicolas Duployez; Jean-Baptiste Micol

Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia

核心结合因子急性髓系白血病中的基因改变和可测量残留疾病

Leukemia

IF13.4

2026-03-260

PRE

Loïc Vasseur; Matthieu Duchmann; Nicolas Duployez; Emmanuel Raffoux; Céline Berthon; Maël Heiblig; Alexis Genthon; Thorsten Braun; Mathieu Leclerc; Delphine Lebon; Sylvain Chantepie; Jean-Baptiste Micol; Juliette Lambert; Christian Récher; Marie-Lorraine Chrétien; Alexandre Iat; Julien Vaidie; Jean-Valère Malfuson; Madalina Uzunov; Arnaud Pigneux; Pierre Peterlin; Sihem Tarfi; Pierre Hirsch; Dominique Penther; Eric Jourdan; Karine Celli-Lebras; Claude Preudhomme; Hervé Dombret; Jérôme Lambert; Nicolas Boissel; Raphaël Itzykson

PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome

PAXIS：一项随机、双盲、安慰剂对照、剂量探索的II期研究（第一部分），随后进行开放标签期（第二部分），以评估Pacritinib在VEXAS综合征患者中的有效性和安全性

Journal of Clinical Medicine

IF2.9

2026-02-270

OAAI

Establishing a consensus definition of VEXAS flare for clinical research

建立VEXAS flare的临床研究共识定义

RHEUMATOLOGY

IF4.4

2025-12-010

PRE

Inflammatory disorders in IDH-mutated myeloid neoplasms: Characteristics and response to IDH inhibitors

IDH突变髓系肿瘤中的炎症性疾病：特征及对IDH抑制剂的应答

HemaSphere

IF14.6

2025-11-250

OAAI

Romain Stammler; Peter Chen; Orianne Debeaupuis; Lin-Pierre Zhao; Mirabelle Ruyer-Thompson; Eve Zakine; Julien Rossignol; Lauriane Goldwirt; Thibault Comont; Maël Heiblig; Lionel Adès; Marie Sebert; Jean-Sébastien Allain; Julien Campagne; Marie-Anne Couturier; Marina Cumin; Marie-Caroline Dalmas; Guillaume Denis; Cécile Devloo; Adrien De Voeght; Louis Drevon; Pierre Duffau; Sophie Georgin-Lavialle; Delphine Gobert; Olivier Kosmider; Frédéric Rieux-Laucat; Noémie Abisror; Estibaliz Lazaro; Jean-Guillaume Lopez; Alexandre Maria; Wladimir Mauhin; Julie Merindol; Claire Merlot; Tristan Mirault; Laurent Pascal; François Perrin; Emmanuel Raffoux; Ramy Rahme; Damien Roos-Weil; Benjamin Terrier; Benjamin Thoreau; Olivier Fain; Pierre Fenaux; Pierre Hirsch; Vincent Jachiet; Jérôme Hadjadj; Arsène Mékinian; MINHEMON

Characterizing VEXAS syndrome in women: Findings from an international multicenter study

表征女性VEXAS综合征：一项国际多中心研究的结果

Journal of Internal Medicine

IF9.2

2025-09-230

PRE

Comparative efficacy and safety of anakinra and canakinumab in patients with VEXAS syndrome – an international multicenter study

阿那白滞素（anakinra）和卡那单抗（canakinumab）在VEXAS综合征患者中的比较疗效与安全性——一项国际多中心研究

Arthritis & Rheumatology

IF10.9

2025-09-220

OAAI

Tali Eviatar MD; Dafne Capelusnik MD; Corrado Campochiaro MD; Valentin Lacombe MD; Vincent Jachiet MD; Michael Zisapel MD; Iftach Sagy MD; Oshrat E. Tayer-Shifman MD; David Ozeri MD; Shaye Kivity MD; Alessandro Tomelleri MD, PhD; Benjamin Terrier MD, PhD; Hagit Peleg MD; Thibault Comont MD; Karim Sacre MD; Pascal Woaye-Hune MD; Laurent Arnaud MD, PhD; Estibaliz Lazaro MD; Vincent Grobost MD; Francois Lifermann MD; Maxime Samson MD, PhD; Samuel Ardois MD; Alice Garnier MD; Alexandre Maria MD; Alain Cantagrel MD; Aurore Meyer MD; Jean-David Bouaziz MD; Mael Heiblig MD; Lorenzo Dagna MD; Elisa Diral MD; Olivier Kosmider MD, PhD; Ori Elkayam MD; Jérôme Hadjadj MD; Sophie Georgin-Lavialle MD, PhD; Olivier Fain MD; Arsene Mekinian MD

Clinical features in VEXAS syndrome: a systematic review

VEXAS综合征的临床特征：一项系统综述

RHEUMATOLOGY

IF4.4

2025-07-018

OAAI

Comparison of induction with arsenic trioxide or chemotherapy in a real-world cohort of patients with high-risk acute promyelocytic leukemia

高危及急性早幼粒细胞白血病患者真实世界队列中三氧化二砷诱导治疗与化疗的比较

Leukemia

IF13.4

2025-06-240

PRE

Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX

阿扎胞苷治疗VEXAS综合征的疗效与安全性：FRENVEX小组的一项大规模回顾性研究

Blood

IF23.1

2025-05-190

PRE

Vincent Jachiet; Olivier Kosmider; Maxime Beydon; Jérôme Hadjadj; Lin-Pierre Zhao; Vincent Grobost; Valentin Lacombe; Guillaume Le Guenno; Yann Nguyen; Jean-Benoît Arlet; Jérémie Dion; Maël Heiblig; Alice Garnier; Maxime Samson; Achille Aouba; Sylvain Thépot; Sophie Dimicoli-Salazar; Fabien Dutasta; Benoît Faucher; Estibaliz Lazaro; Véronique Morel; Antoine Néel; Roderau Outh; Holy Bezanahary; Julien Rossignol; Anne-Sophie Alary; Audrey Bidet; Pauline Blateau; Anne Bouvier; Guilaine Boursier; Matthieu Decamp; Benjamin Lebecque; Yannick Le Bris; Pierre Sujobert; Alice Marceau-Renaut; Cédric Pastoret; David Rizzo; Nathalie Boiret-Dupré; Lara Boucher; Stéphanie Dulucq; Franck Genevieve; Cassandra Jadeau; Pierre Lemaire; Romain Vazquez; Jean-Baptiste Rieu; Olivier Fain; Sophie Georgin-Lavialle; Lucie Rigolot; Lise Larcher; Pierre Hirsch; Benjamin Terrier; Pierre Fenaux; Arsène Mékinian; Thibault Comont

Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia

红细胞压积对旋转血栓弹力ometry测量的凝血功能的影响：在健康受试者和真性红细胞增多症患者中的研究

SEMINARS IN THROMBOSIS AND HEMOSTASIS

IF4.1

2025-04-250

PRE

Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?

长期B细胞淋巴瘤应答者接受CD19定向CAR T细胞治疗后出现的髓系肿瘤，风险是否随时间推移而增加？

LEUKEMIA

IF13.4

2025-04-240

Myeloid neoplasm inspired intensive therapy in VEXAS syndrome: A single-centre experience

髓系肿瘤启发的VEXAS综合征中的强化治疗：一项单中心经验

BRITISH JOURNAL OF HAEMATOLOGY

IF3.8

2025-04-080

OAAI

Indications and contraindications to platelet-rich plasma injections in musculoskeletal diseases in case of infectious, oncological and haematological comorbidities: A 2025 formal consensus from the GRIIP (International Research Group on Platelet Injections)

KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY

IF5

2025-04-010

OAAI

Eymard, Florent; Louati, Karine; Noel, Eric; Abouqal, Redouane; Adam, Philippe; Allali, Fadoua; Antherieu, Gabriel; Caers, Jo; Cognasse, Fabrice; Collado, Herve; Darrieutort-Laffite, Christelle; Frere, Corinne; Frey, Alain; Gavillet, Mathilde; Gremeaux, Vincent; Heiblig, Mael; Jerusalem, Guy; Joly, Charlotte; Kaux, Jean-Francois; Lamontagne, Martin; Leclerc, Mathieu; Leonard, Philippe; Lepeule, Raphael; Lopez-Trabada-Ataz, Daniel; Magalon, Jeremy; Michel, Fabrice; Ornetti, Paul; Oury, Cecile; Pons-Tostivint, Elvire; Real, Fernando; Robert, Ghislaine; Sanchez, Mikel; Silvestre, Alain; Bard, Herve

Maël Heiblig

个人简介

教育背景

工作经历

荣誉奖项

研究方向